Cargando…

Novel parameter for cancer chemosensitivity to fibroblast growth factor receptor inhibitors

Fibroblast growth factor receptor inhibitors (FGFRi) were introduced into clinical trials on several cancer types and found to be particularly efficacious on urothelial cancer and cholangiocarcinoma. Although many enrolled patients responded well in clinical trials, there were some patients who did...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kitano, Shoichi, Yamamoto, Takehito, Taketo, Makoto Mark
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633288/ https://www.ncbi.nlm.nih.gov/pubmed/35950366 http://dx.doi.org/10.1111/cas.15523

Ejemplares similares

Chemosensitivity of Patient-Derived Cancer Stem Cells Identifies Colorectal Cancer Patients with Potential Benefit from FGFR Inhibitor Therapy
por: Yamamoto, Takehito, et al.
Publicado: (2020)

Thyroid dysfunction from inhibitor of fibroblast growth factor receptor
por: Ahn, Jeffrey, et al.
Publicado: (2019)

Calciphylaxis associated with the fibroblast growth factor receptor inhibitor erdafitinib
por: Macklis, Paul, et al.
Publicado: (2020)

Reversible Retinopathy Associated with Fibroblast Growth Factor Receptor Inhibitor
por: Patel, Saagar N., et al.
Publicado: (2022)

Trichiasis and dry eye syndrome in two patients on novel fibroblast growth factor receptor inhibitor therapies
por: Vinson, Kyle B., et al.
Publicado: (2020)

First‐in‐human phase I study of E7090, a novel selective fibroblast growth factor receptor inhibitor, in patients with advanced solid tumors
por: Koyama, Takafumi, et al.
Publicado: (2020)

Serous Retinopathy Associated With Combination MEK and Fibroblast Growth Factor Receptor Inhibitor
por: Day, H. Russell, et al.
Publicado: (2023)

Fibroblast Growth Factor Receptor (FGFR) Inhibitors in Urothelial Cancer
por: Garje, Rohan, et al.
Publicado: (2020)

Fibroblast growth factor receptor inhibitor therapy induced calcinosis cutis treated with sodium thiosulfate
por: Qian, Justin, et al.
Publicado: (2022)

Fibroblast Growth Factor Receptors (FGFRs): Structures and Small Molecule Inhibitors
por: Dai, Shuyan, et al.
Publicado: (2019)

Transformation From Adenocarcinoma to Pleomorphic Carcinoma as an Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
por: Nishimatsu, Kanako, et al.
Publicado: (2021)

Growth Factor Receptors and Apoptosis Regulators: Signaling Pathways, Prognosis, Chemosensitivity and Treatment Outcomes of Breast Cancer
por: Sarkar, Siddik, et al.
Publicado: (2009)

Involvement of estrogen in phosphorus-induced nephrocalcinosis through fibroblast growth factor 23
por: Takasugi, Satoshi, et al.
Publicado: (2020)

Efficacy of futibatinib, an irreversible fibroblast growth factor receptor inhibitor, in FGFR-altered breast cancer
por: Saridogan, Turcin, et al.
Publicado: (2023)

Calciphylaxis Cutis Associated With Fibroblast Growth Factor Receptor (FGFR) Inhibitor Therapy: A New Challenge
por: Griffith, Paige, et al.
Publicado: (2022)

A novel S269C mutation in fibroblast growth factor receptor 3 in a Japanese child with hypochondroplasia
por: Takahashi, Ikuko, et al.
Publicado: (2018)

In vivo effects of AZD4547, a novel fibroblast growth factor receptor inhibitor, in a mouse model of endometriosis
por: Santorelli, Sara, et al.
Publicado: (2021)

Suppression of human epidermal growth factor receptor 2 via interference increases the chemosensitivity of ovarian carcinoma
por: SONG, XIAOPING, et al.
Publicado: (2016)

Discovery of Novel Tetrahydro-β-carboline Containing Aminopeptidase N Inhibitors as Cancer Chemosensitizers
por: Xing, Xiaoyan, et al.
Publicado: (2022)

Fibroblast Growth Factor Receptor Signaling in Skin Cancers
por: Czyz, Malgorzata
Publicado: (2019)

Role of fibroblast growth factor receptor 4 in cancer
por: Tang, Shuya, et al.
Publicado: (2018)

Hepatocyte growth factor ameliorates dermal sclerosis in the tight-skin mouse model of scleroderma
por: Iwasaki, Tsuyoshi, et al.
Publicado: (2006)

Central retinal vein occlusion in the setting of fibroblast growth factor receptor inhibition
por: Foulsham, William, et al.
Publicado: (2022)

Fibroblast growth factor receptor 3 overexpression mediates ALK inhibitor resistance in ALK‐rearranged non–small cell lung cancer
por: Sakashita, Takuya, et al.
Publicado: (2022)

Fibroblast Growth Factor Receptor Functions in Glioblastoma
por: Jimenez-Pascual, Ana, et al.
Publicado: (2019)

Comprehensive functional evaluation of variants of fibroblast growth factor receptor genes in cancer
por: Nakamura, Ikuko Takeda, et al.
Publicado: (2021)

Design and characteristics of cytotoxic fibroblast growth factor 1 conjugate for fibroblast growth factor receptor-targeted cancer therapy
por: Szlachcic, Anna, et al.
Publicado: (2016)

Mutational identification of fibroblast growth factor receptor 1 and fibroblast growth factor receptor 2 genes in craniosynostosis in Indian population
por: Pandey, Rajeev Kumar, et al.
Publicado: (2013)

Caveolin-1 is a negative regulator of tumor growth in glioblastoma and modulates chemosensitivity to temozolomide
por: Quann, Kevin, et al.
Publicado: (2013)

A novel fibroblast growth factor receptor 1 inhibitor protects against cartilage degradation in a murine model of osteoarthritis
por: Xu, Wei, et al.
Publicado: (2016)

The synthetic inhibitor of Fibroblast Growth Factor Receptor PD166866 controls negatively the growth of tumor cells in culture
por: Risuleo, Gianfranco, et al.
Publicado: (2009)

Plasma intact fibroblast growth factor 23 levels in women with anorexia nervosa
por: Otani, Makoto, et al.
Publicado: (2008)

Importin β–Mediated Nuclear Import of Fibroblast Growth Factor Receptor: Role in Cell Proliferation
por: Reilly, John F., et al.
Publicado: (2001)

Fibroblast growth factor receptor‐1 protein expression is associated with prognosis in estrogen receptor‐positive/human epidermal growth factor receptor‐2‐negative primary breast cancer
por: Tomiguchi, Mai, et al.
Publicado: (2016)

Differential regulation of fibroblast growth factor receptor 1 trafficking and function by extracellular galectins
por: Kucińska, Marika, et al.
Publicado: (2019)

Therapeutic Targeting of Fibroblast Growth Factor Receptors in Gastric Cancer
por: Inokuchi, Mikito, et al.
Publicado: (2015)

Fibroblast Growth Factor Receptor 2 Signaling in Breast Cancer
por: Lei, Haipeng, et al.
Publicado: (2017)

Fibroblast growth factor receptor fusions in cancer: opportunities and challenges
por: Chen, Lingfeng, et al.
Publicado: (2021)

Downregulation of SMC1A inhibits growth and increases apoptosis and chemosensitivity of colorectal cancer cells
por: Li, Jin, et al.
Publicado: (2015)

Expression of basic fibroblast growth factor and its receptor in human pancreatic carcinomas.
por: Ohta, T., et al.
Publicado: (1995)

Cannot write session to /tmp/vufind_sessions/sess_aacb3ds030u3hf9gtvperkeme3